Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 16.61% is 73% above its 5-year average of 9.62%, near the high end of its 5-year range (5.30%–16.61%).
As of the fiscal period ended Wednesday, December 31, 2025. 23.91% above its 12-month average of 13.40%.
Annual fiscal-year return on invested capital; no daily interpolation.
RETURN ON INVESTED CAPITAL (ROIC)
16.61%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
13.40%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
11.07%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
9.62%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
0.14%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-13.87%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
-26.40%
CURRENT VS TTM AVG
+23.91%
CURRENT VS 3Y AVG
+49.98%
CURRENT VS 5Y AVG
+72.69%
CURRENT VS 10Y AVG
+11920.39%
CURRENT VS 15Y AVG
+219.79%
CURRENT VS 20Y AVG
+162.91%
SECTOR MEDIAN · HEALTHCARE
8.53%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
+94.72%
vs the sector median at left
DexCom, Inc.
Market Cap
$27.61B
Return on Invested Capital (ROIC)
16.61%
TTM Avg
13.40%
3Y Avg
11.07%
5Y Avg
9.62%
Market Cap
$27.56B
Return on Invested Capital (ROIC)
8.84%
TTM Avg
8.56%
3Y Avg
8.37%
5Y Avg
9.38%
Market Cap
$28.33B
Return on Invested Capital (ROIC)
19.56%
TTM Avg
18.66%
3Y Avg
17.73%
5Y Avg
16.77%
Market Cap
$26.82B
Return on Invested Capital (ROIC)
35.46%
TTM Avg
38.26%
3Y Avg
37.51%
5Y Avg
36.01%
Market Cap
$29.85B
Return on Invested Capital (ROIC)
6.62%
TTM Avg
7.71%
3Y Avg
8.64%
5Y Avg
10.90%
Market Cap
$25.15B
Return on Invested Capital (ROIC)
8.43%
TTM Avg
7.70%
3Y Avg
8.24%
5Y Avg
10.04%
Market Cap
$24.42B
Return on Invested Capital (ROIC)
17.57%
TTM Avg
18.00%
3Y Avg
20.73%
5Y Avg
22.79%
Market Cap
$24.34B
Return on Invested Capital (ROIC)
7.39%
TTM Avg
6.30%
3Y Avg
5.64%
5Y Avg
7.56%
Market Cap
$31.31B
Return on Invested Capital (ROIC)
-13.41%
TTM Avg
-4.17%
3Y Avg
-0.53%
5Y Avg
0.76%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| DexCom, Inc. (DXCM) | $27.61B | 16.61% | 13.40% | 11.07% | 9.62% |
| GE HealthCare Technologies Inc. (GEHC)vs › | $27.56B | 8.84% | 8.56% | 8.37% | 9.38% |
| ResMed Inc. (RMD)vs › | $28.33B | 19.56% | 18.66% | 17.73% | 16.77% |
| Mettler-Toledo International Inc. (MTD)vs › | $26.82B | 35.46% | 38.26% | 37.51% | 36.01% |
| Biogen Inc. (BIIB)vs › | $29.85B | 6.62% | 7.71% | 8.64% | 10.90% |
| Quest Diagnostics Incorporated (DGX)vs › | $25.15B | 8.43% | 7.70% | 8.24% | 10.04% |
| Waters Corporation (WAT)vs › | $24.42B | 17.57% | 18.00% | 20.73% | 22.79% |
| Labcorp Holdings Inc. (LH)vs › | $24.34B | 7.39% | 6.30% | 5.64% | 7.56% |
| Centene Corp. (CNC)vs › | $31.31B | -13.41% | -4.17% | -0.53% | 0.76% |
| Zoetis Inc. (ZTS)vs › | $31.59B | 21.54% | 21.87% | 20.30% | 19.27% |
ROIC
16.6%
ROE
31.5%
ROIC = NOPAT / Invested Capital
Return on invested capital measures the after-tax return a company earns on all capital (debt and equity) invested in the business.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-12-31 | 16.61% |
| 2024-12-31 | 10.20% |
| 2023-12-31 | 9.63% |
| 2022-12-31 | 7.86% |
| 2021-12-31 | 5.30% |
| 2020-12-31 | 8.11% |
| 2019-12-31 | 6.74% |
| 2018-12-31 | -11.00% |
| 2017-12-31 | -5.55% |
| 2016-12-31 | -21.27% |
| 2015-12-31 | -25.11% |
| 2014-12-31 | -14.70% |
| 2013-12-31 | -31.21% |
| 2012-12-31 | -62.75% |
| 2011-12-31 | -42.32% |
| 2010-12-31 | -72.39% |
| 2009-12-31 | -157.76% |
| 2008-12-31 | -168.77% |
| 2007-12-31 | -66.50% |
| 2006-12-31 | -81.88% |
| 2005-12-31 | -0.07% |
| 2004-12-31 | -50.62% |
| 2003-12-31 | -51.48% |
| 2002-12-31 | 0.00% |
| 2001-12-31 | 0.00% |
| 2000-12-31 | 0.00% |
